Jim Firn

StepStone Group Private Debt AG is a hedge fund management firm headquartered in Zurich, Switzerland. The firm was founded in 1998 and formerly known as Swiss Capital Alternative Investments AG. They are a subsidiary of StepStone Group, Inc. (NASDAQ: STEP) in the US. StepStone Group Private Debt offers flexible, adaptive solutions to cover illiquid and liquid debt, which enables tailored access through separately managed, advisory accounts, and focused commingled funds.

StepStone Group Europe Alternative Investments Ltd. (SGEAIL) is an alternative investment management firm headquartered in Dublin, Ireland. The firm was founded in 2005 as Swiss Capital Invest Holding (Dublin) Ltd. They are a wholly-owned subsidiary of Swiss Capital Alternative Investments AG, which is owned by StepStone Group, Inc. (NASDAQ: STEP) in the US. SGEAIL provides investment management and supervisory services to institutional entities and private markets funds with a variety of investment strategies.

Swiss Capital Group AG provides investment banking advisory services. It offers corporate finance, asset management, investment and product placement services. The company was founded in 1998 and is headquartered in Zurich, Switzerland.

StepStone Group LP (StepStone) is a private equity firm founded in 2006 by Monte M. Brem, Tom Porter Keck and Jose A. Fernandez. The firm is headquartered in New York.

Artefact Partners LLP is the hedge fund management subsidiary of Artefact Partners (Holding) Ltd. in Great Britain. The firm was founded by Richard Boon and Damian O'Brien in 2005. Headquartered in Wallington, Artefact Partners manages the assets of high-net-worth clients.

M&G Wealth Investment LLP (M&G Wealth) is an asset management firm headquartered in London, UK. Formerly TCF Fund Managers LLP, the firm was founded by Dan Norman and Gary Mairs in 2003 as Rutherglen Capital LLP. They were acquired by M&G Plc (LON: MNG; OTCMKTS: MGPUF) in 2022. M&G Wealth provides a variety of investment solutions to their clients.

Oncomark Ltd. Engages in the development and application of biomarker panels. The firm’s products include OncoMasTR and pipeline assays. The company was founded by William M. Gallagher and Steve Carl Penney in 2007 and is headquartered in Belfield, Ireland.